↓ Skip to main content

Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data

Overview of attention for article published in BMC Health Services Research, July 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data
Published in
BMC Health Services Research, July 2014
DOI 10.1186/1472-6963-14-286
Pubmed ID
Authors

Cathryn A Carroll, Kathleen A Fairman, Maureen J Lage

Abstract

For patients with multiple sclerosis (MS), previous research identified key disease sequelae as important cost drivers and suggested that among users of disease-modifying drugs (DMDs) in 2004, DMDs represented 73% of the total cost of care. More recent studies were limited to incident disease/treatment and/or excluded DMDs from cost estimates. To support contemporary pharmacoeconomic analyses, the present study was conducted to provide updated information about MS-related costs and cost drivers including DMDs.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Brazil 1 1%
Unknown 66 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 26%
Student > Master 10 15%
Researcher 8 12%
Other 7 10%
Student > Postgraduate 5 7%
Other 12 18%
Unknown 8 12%
Readers by discipline Count As %
Medicine and Dentistry 11 16%
Economics, Econometrics and Finance 10 15%
Pharmacology, Toxicology and Pharmaceutical Science 8 12%
Psychology 5 7%
Neuroscience 5 7%
Other 16 24%
Unknown 13 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2014.
All research outputs
#7,164,590
of 9,726,436 outputs
Outputs from BMC Health Services Research
#2,790
of 3,502 outputs
Outputs of similar age
#113,033
of 183,798 outputs
Outputs of similar age from BMC Health Services Research
#94
of 114 outputs
Altmetric has tracked 9,726,436 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,502 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,798 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.